NeoStem Unfazed By Hiccup Over Its AMR-001 Cardiovascular Stem Cell … – Forbes
|
NeoStem Unfazed By Hiccup Over Its AMR-001 Cardiovascular Stem Cell …
Forbes NeoStem has rebounded this week after a Seeking Alpha blog post suggested its AMR-001 stem cell treatment for cardiovascular disease was unlikely to work. AMR-001, for which NeoStem is now enrolling patients for Phase 2 clinical trial, is an adult stem … |
